<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        97-276-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PRIORIX 0.5ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MUMPS VIRUS (JERYL LYNN, STRAIN RIT 4385) LIVE ATTENUATED,MEASLES VIRUS (SCHWARZ) LIVE ATTENUATED,RUBELLA VIRUS (WISTAR RA 27/3) LIVE ATTENUATED
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5011.87,1000,1000
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        51.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GLAXOSMITHKLINE (GSK)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GLAXOSMITHKLINE (GSK)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07BD52
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Priorix is a vaccine for use in children from 9 months up, adolescents and adults to protect them against illnesses caused by measles, mumps and rubella viruses.</p><p><strong>How Priorix works</strong><br />When a person is vaccinated with Priorix, the immune system (the body&rsquo;s natural defence system) will make antibodies to protect the person from being infected by measles, mumps and rubella viruses.</p><p>Although Priorix contains live viruses, they are too weak to cause measles, mumps or rubella in healthy people.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Priorix should not be given if</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are allergic against any of the components of this vaccine (listed in section 6).&nbsp; Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are known to be allergic to neomycin (an antibiotic agent).&nbsp; A known contact dermatitis (skin rash when the skin is in direct contact with allergens such as neomycin) should not be a problem but talk to your doctor first;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a severe infection with a high temperature.&nbsp; In these cases, the vaccination will be postponed until recovery.&nbsp; A minor infection such as a cold should not be a problem, but talk to your doctor first;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have any illness (such as Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS)) or take any medicine that weakens the immune system. &nbsp;Whether you receive the vaccine will depend upon the level of your immune defences;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are pregnant.&nbsp; In addition, pregnancy should be avoided for 1 month following vaccination.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before you receive Priorix if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have disorders of the central nervous system, a history of convulsion accompanying high fever or family history of convulsions.&nbsp; In case of high fever following vaccination please consult your doctor promptly;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had a severe allergic reaction to egg protein;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have had a side effect after vaccination against measles, mumps or rubella that involved easy bruising or bleeding for longer than usual (see section 4);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have weakened immune system (e.g. such as HIV infection).&nbsp; You should be closely monitored as the responses to the vaccines may not be sufficient to ensure a protection against the illness (see section 2 &ldquo;Priorix should not be given if&rdquo;).</p><p>&nbsp;</p><p>Fainting can occur (mostly in adolescents) following, or even before, any needle injection.&nbsp; Therefore tell the doctor or nurse if you fainted with a previous injection.</p><p>&nbsp;</p><p>If you are vaccinated within 72 hours after contact with someone with measles, Priorix will to some extent protect you against the disease.</p><p>&nbsp;</p><p><em>Children below 12 months of age</em></p><p>Children vaccinated in their first year of life may not be fully protected.&nbsp; Your doctor will advise if additional doses of vaccine are needed.</p><p>&nbsp;</p><p>As with all vaccines, Priorix may not fully protect all people who are vaccinated.</p><p>&nbsp;</p><p><strong>Other medicines and</strong><strong> Priorix </strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor if you are taking, have recently taken or might take any other medicines (or other vaccines).</p><p>&nbsp;</p><p>Priorix may be given at the same time you receive other vaccines such as diphtheria, tetanus, pertussis (acellular), <em>Haemophilus influenzae</em> type b, oral or inactivated polio, hepatitis A, hepatitis B, varicella, meningococcal serogroup B vaccines as well as meningococcal serogroup C, meningococcal serogroups A, C, W-135 and Y and pneumococcal conjugate vaccines. Talk to your doctor or nurse for further information.</p><p>A different injection site will be used for each vaccine.</p><p>&nbsp;</p><p>If not given at the same time, an interval of at least one month is recommended between administration of Priorix and other live attenuated vaccines.</p><p>&nbsp;</p><p>Your doctor may delay vaccination for at least 3 months if you have received a blood transfusion or human antibodies (immunoglobulins).</p><p>&nbsp;</p><p>If a tuberculin test is to be performed, it should be done either any time before, simultaneously with, or 6 weeks after vaccination with Priorix.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>Priorix should not be administered to pregnant women.&nbsp;</p><p>&nbsp;</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before the vaccination is given.&nbsp; Also, it is important that you do not become pregnant within one month after having the vaccine.&nbsp; During this time you should use an effective method of birth control to avoid pregnancy.</p><p>&nbsp;</p><p>In case of inadvertent vaccination of pregnant women with Priorix, this should not be a reason for termination of pregnancy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Priorix is injected under the skin or into the muscle, either in the upper arm or in the outer thigh.</p><p>Priorix is intended for children from 9 months up, adolescents and adults.&nbsp; The appropriate time and number of injections that will be given to you will be determined by your doctor on the basis of appropriate official recommendations.</p><p>The vaccine should never be given into a vein.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this vaccine can cause side effects, although not everybody gets them.</p><p>Side effects that occurred during clinical trials with Priorix were as follows: &nbsp;&nbsp;</p><p>&nbsp;</p><p><strong>Very common </strong>(these may occur with more than 1 in 10 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; redness at the injection site</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever of 38&deg;C or higher</p><p><strong>Common </strong>(these may occur with up to 1 in 10 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain and swelling at the injection site</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever higher than 39.5&deg;C</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash (spots)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; upper respiratory tract infection</p><p><strong>Uncommon </strong>(these may occur with up to 1 in 100 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infection of the middle ear</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swollen lymph glands (glands in the neck, armpit or groin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nervousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal crying</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to sleep (insomnia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; redness, irritation and watering of the eyes (conjunctivitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bronchitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swollen parotid glands (glands in the cheek)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&nbsp;</p><p><strong>Rare </strong>(these may occur with up to 1 in 1,000 doses of the vaccine):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; convulsions accompanying high fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions</p><p>&nbsp;</p><p>After the marketing of Priorix, the following side effects have been reported on a few occasions:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint and muscle pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; punctual or small spotted bleeding or bruising more easily than normal due to a drop in platelets</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sudden life-threatening allergic reaction</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infection or inflammation of the brain, spinal cord and peripheral nerves resulting in temporary difficulty when walking (unsteadiness) and/or temporary loss of control of bodily movements, inflammation of some nerves, possibly with pins and needles or loss of feeling or normal movement (Guillain-Barr&eacute; syndrome)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; narrowing or blockage of blood vessels</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erythema multiforme (symptoms are red, often itchy spots, similar to the rash of measles, which starts on the limbs and sometimes on the face and the rest of the body)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; measles and mumps like symptoms (including transient, painful swelling of the testicles and swollen glands in the neck)</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>&nbsp;</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse.&nbsp; This includes any possible side effects not listed in this leaflet.&nbsp;</p><p>&nbsp;</p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><ul><li>Fax: +966-11-205-7662</li><li>Reporting Hotline: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: saudi.safety@gsk.com</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GlaxoSmithKline - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/<u> </u></li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this vaccine out of the sight and reach of children.<br /><br />Do not use this vaccine after the expiry date which is stated on the carton after EXP.</p><p>Store and transport refrigerated (2&deg;C - 8&deg;C)<br />Do not freeze<br />Store in the original package in order to protect from light</p><p>After reconstitution, the vaccine should be administered promptly.&nbsp; If this is not possible, it must be stored in the refrigerator (2&deg;C - 8&deg;C) and used within 8 hours of reconstitution.<br /><br />Do not throw away any medicines via wastewater or household waste.&nbsp; Ask your pharmacist how to throw away medicines you no longer use.&nbsp; These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substances are: measles, mumps and rubella live attenuated viruses.</p><p>The other ingredients are:<br /><u>Powder</u>: amino acids, lactose (anhydrous), mannitol, sorbitol<br /><u>Solvent</u>: water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Priorix is presented as a powder and solvent for solution for injection (powder in a vial for 1 dose and solvent in a pre-filled syringe (0.5 ml)) with or without needles in the following pack sizes:
-	with 1 separate needle: pack sizes of 20 or 40
-	with 2 separate needles: pack sizes of 1, 10, 25 or 100
-	without needle: pack sizes of 1, 10, 20, 25, 40 or 100

Priorix is supplied as a white to slightly pink powder and a clear colourless solvent (water for injections) for reconstituting the vaccine.

Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufactured by: </strong></p><p>GlaxoSmithKline Biologicals s.a.</p><p>89, rue de l&rsquo;Institut - 1330 Rixensart</p><p>Belgium Tel: (32) 2 656 81 11 Fax: (32) 2 656 80 00</p><p>&nbsp;</p><p><strong>packed by: </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>*member of the GlaxoSmithKline group of companies</p><p><strong>&nbsp;</strong></p><p><strong>Marketing Authorization holder: </strong></p><p>Glaxo Saudi Arabia Ltd.* Jeddah, KSA</p><p>Address: P.O. Box 22617 Jeddah 21416 &ndash; Kingdom of Saudi Arabia</p><p>*member of the GlaxoSmithKline group of companies</p><p>&nbsp;</p><p><strong>Priorix is a trademark owned by or licensed to the GSK group of companies</strong></p><p><strong>&nbsp;</strong></p><p><strong>&copy; 2021 GSK group of companies or its licensor</strong></p><table border="2" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td><p>To report any side effect(s):</p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><ul><li>Fax: +966-11-205-7662</li><li>Reporting Hotline: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: saudi.safety@gsk.com<u>&nbsp; </u></li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul></td></tr></tbody></table><p>&nbsp;</p><table border="2" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td><p><strong>THIS IS A MEDICAMENT</strong></p><p>- Medicament is a product which affects your health, and its consumption contrary to instructions is dangerous for you.</p><p>- Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>- The doctor and the pharmacist are experts in medicine, its benefits and risks.</p><p>- Do not by yourself interrupt the period of treatment prescribed for you.</p><p>- Do not repeat the same prescription without consulting your doctor.</p><p>- Keep all medicine out of reach of children.</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p></td></tr></tbody></table><p><strong>Priorix, powder and solvent for solution for injection in a pre-filled syringe</strong></p><p><strong>Measles, Mumps and Rubella vaccine (live)</strong></p><p><strong>&nbsp;</strong></p><p><strong>The following information is intended for healthcare professionals only:</strong></p><p>&nbsp;</p><p>As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.</p><p>&nbsp;</p><p>Alcohol and other disinfecting agents must be allowed to evaporate from the skin before injection of the vaccine since they can inactivate the attenuated viruses in the vaccine.</p><p>&nbsp;</p><p>Priorix should under no circumstances be administered intravascularly.</p><p>&nbsp;</p><p>In the absence of compatibility studies, the medicinal product must not be mixed with other medicinal products.</p><p>&nbsp;</p><p>The solvent and the reconstituted vaccine should be inspected visually for any foreign particulate matter and/or variation of physical aspects prior to reconstitution or administration.&nbsp; In the event of either being observed, do not use the solvent or the reconstituted vaccine.</p><p>&nbsp;</p><p>The vaccine must be reconstituted by adding the entire content of the pre-filled syringe of solvent to the vial containing the powder.&nbsp;</p><p>To attach the needle to the syringe, carefully read the instructions given with pictures 1 and 2. &nbsp;However, the syringe provided with Priorix might be slightly different (without screw thread) than the syringe illustrated.</p><p>In that case, the needle should be attached without screwing.</p><p>&nbsp;</p><p><img alt="" width="575" height="342" src="data:image/png;base64,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" /></p><p>Always hold the syringe by the barrel, not by the syringe plunger or the Luer Lock Adaptor (LLA), and maintain the needle in the axis of the syringe (as illustrated in picture 2). Failure to do this may cause the LLA to become distorted and leak.</p><p>&nbsp;</p><p>During assembly of the syringe, if the LLA comes off, a new vaccine dose (new syringe and vial) should be used.</p><p>&nbsp;</p><p>1.&nbsp;&nbsp; Unscrew the syringe cap by twisting it anticlockwise (as illustrated in picture 1).</p><p>Whether the LLA is rotating or not, please follow below steps:</p><p>&nbsp;</p><p>2.&nbsp;&nbsp; Attach the needle to the syringe by gently connecting the needle hub into the LLA and rotate a quarter turn clockwise until you feel it lock (as illustrated in picture 2).</p><p>&nbsp;</p><p>3.&nbsp;&nbsp; Remove the needle protector, which may be stiff.</p><p>&nbsp;</p><p>4.&nbsp;&nbsp; Add the solvent to the powder. The mixture should be well shaken until the powder is completely dissolved in the solvent.</p><p>&nbsp;</p><p>Due to minor variation of its pH, the reconstituted vaccine may vary in colour from clear peach to fuchsia pink without deterioration of the vaccine potency.</p><p>&nbsp;</p><p>5.&nbsp;&nbsp; Withdraw the entire contents of the vial and administer it.</p><p>&nbsp;</p><p>6.&nbsp;&nbsp; A new needle should be used to administer the vaccine. Unscrew the needle from the syringe and attach the injection needle by repeating step 2 above.</p><p>&nbsp;</p><p>After reconstitution, the vaccine should be administered promptly.&nbsp; If this is not possible, it must be stored in the refrigerator (2&deg;C - 8&deg;C) and used within 8 hours of reconstitution. &nbsp;&nbsp;</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: UK v14
Date of issue:  May 2020

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">Priorix هو لقاح خاص بالأطفال من سن 9 أشهر فما فوق والمراهقين والبالغين لحمايتهم من الأمراض التي تسببها فيروسات الحصبة والنكاف والحصبة الألمانية.</p><p dir="RTL"><strong>آلية عمل </strong><strong>Priorix</strong></p><p dir="RTL">عند تطعيم شخص ما بلقاح Priorix، يُكوّن الجهاز المناعي (الجهاز المناعي الطبيعي بالجسم) مضادات حيوية تحمي الشخص من الإصابة بفيروسات الحصبة والنكاف والحصبة الألمانية.</p><p dir="RTL">وبالرغم من أن Priorix يحتوي على فيروسات حية، فهي ضعيفة للغاية بحيث لا تسبب إصابة الأشخاص الأصحاء بالحصبة أو النكاف أو الحصبة الألمانية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم إعطاء </strong><strong>Priorix</strong><strong> في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه أي من مكونات هذا اللقاح (مدرجة في القسم 6). قد تشمل علامات حدوث تفاعل حساسية ظهور الطفح الجلدي المثير للحكة&rlm;‫ وضيق التنفس وتورم الوجه أو اللسان؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كان من المعروف أنك تعاني من حساسية تجاه نيوميسِين (عامل مضاد حيوي). ليس من المُفترَض أن يمثل التهاب الجلد التماسي المعروف (الطفح الجلدي عند ملامسة البشرة بشكل مباشر لأحد العوامل المسببة للحساسية مثل نيوميسِين) مشكلة، لكن يجب استشارة الطبيب أولاً؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كنت تعاني من عدوى شديدة مع ارتفاع في درجة الحرارة. ففي هذه الحالات، قد يتم تأجيل التطعيم باللقاح حتى يتم الشفاء. وليس من المُفترَض أن يمثل وجود عدوى بسيطة مثل نزلة البرد مشكلة، لكن يجب استشارة الطبيب أولاً؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كنت مصابًا بأي مرض (مثل فيروس نقص المناعة البشرية (HIV) أو متلازمة نقص المناعة المكتسب (الإيدز))، أو تتناول أي دواء يُضعِف الجهاز المناعي. وسيتوقف تطعيمك باللقاح من عدمه على مستوى دفاعاتك المناعية؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كنتِ حاملاً. علاوة على ذلك، ينبغي تجنُّب الحمل لمدة شهر واحد عقب التطعيم باللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يجب استشارة الطبيب أو الصيدلاني قبل تلقي Priorix في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطرابات في الجهاز العصبي المركزي أو لديك تاريخ مرضي من الإصابة بتشنجات<br />تصاحبها حمى عالية أو تاريخ مرضي عائلي من الإصابة بتشنجات. في حالة الحمى العالية عقب التطعيم باللقاح، يُرجى استشارة طبيبك على الفور؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كنت قد تعرضت في أي وقت سابق للإصابة بحساسية شديدة لبروتين البيض؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا ظهر عليك بعد التطعيم باللقاح المضاد للحصبة أو النكاف أو الحصبة الألمانية أثر جانبي تضمّن الإصابة بكدمات أو النزف بشكل سهل لمدة أطول مما هو معتاد (انظر القسم 4)؛</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كان جهازك المناعي ضعيفًا (على سبيل المثال عند الإصابة بعدوى نقص المناعة البشرية). يجب مراقبتك عن كثب لأنه قد لا تكون الاستجابات للقاحات كافية لضمان الحماية من المرض (انظر القسم 2 &quot;يجب عدم تعاطي Priorix في الحالات التالية&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يحدث إغماء (بين المراهقين في معظم الأحيان) بعد أي عملية حقن بإبرة أو حتى قبل الحقن بها. وبالتالي يجب إبلاغ الطبيب أو الممرضة إذا كنت قد أُصبت بالإغماء عند حقنه في السابق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تم تطعيمك باللقاح خلال 72 ساعة بعد ملامسة شخص ما مصاب بالحصبة، فسيحميك Priorix من المرض<br />بعض الشيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الأطفال دون </em><em>12</em><em> شهرًا</em></p><p dir="RTL">قد لا يوفر اللقاح حماية كاملة للأطفال الذين يتم تطعيمهم في عامهم الأول من العمر. وسيقدم لك طبيبك المشورة<br />بشأن ما إذا كنت بحاجة إلى جرعات إضافية من اللقاح أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما هو الحال مع جميع اللقاحات، قد لا يوفر Priorix حماية كاملة لبعض الأشخاص الذين يتم تطعيمهم به.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى و</strong><strong>Priorix</strong><strong> </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">أخبر الطبيب إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى (أو لقاحات أخرى).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن إعطاء Priorix في الوقت نفسه مع تعاطيك لقاحات أخرى، مثل اللقاح (غير الخلوي) للخناق والتيتانوس<br />والشاهوق و<em>لقاح الإنفلونزا المستدمية</em> من النوع ب ولقاح شلل الأطفال المعطّل أو الفموي ولقاح الكبد الوبائي A وB ولقاح الحماق ولقاحات المكورات السحائية B وC و A وC وW-135 وY ولقاحات المكورات العنقودية الرئوية. استشر الطبيب أو الممرضة للحصول على مزيد من المعلومات.</p><p dir="RTL">ولكن يلزم حقن كل لقاح في موضع حقن مختلف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم يتم إعطاء Priorix واللقاحات الحية الموهنة الأخرى في الوقت نفسه، يوصى بمدة فاصلة بينهما لا تقل عن شهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يؤجل الطبيب التطعيم باللقاح لمدة 3 أشهر على الأقل إذا كان قد تم نقل دم أو مضادات حيوية بشرية (غلوبولين مناعي) لك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">وإذا لزم إجراء فحص التوبركولين، يجب القيام بذلك إما في أي وقت قبل التطعيم بلقاح Priorix، أو بشكل متزامن مع التطعيم به، أو بعد التطعيم به بمدة 6 أسابيع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">يجب عدم إعطاء Priorix للنساء الحوامل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين رضاعةً طبيعية أو تعتقدين أنكِ ربما تكونين حاملاً أو تخططين للإنجاب، يجب استشارة الطبيب أو الصيدلاني قبل التطعيم باللقاح. ومن المهم أيضًا تجنّب الحمل بعد التطعيم باللقاح بمدة شهر. وينبغي في أثناء هذه الفترة استخدام وسيلة فعَّالة لتحديد النسل لتجنُّب الحمل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة التطعيم غير المتعمَّد للسيدات الحوامل بلقاح Priorix، ينبغي ألا يكون ذلك دافعًا للإجهاض</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتم حقن Priorix أسفل الجلد أو في العضل إما في أعلى الذراع أو في الجانب الخارجي للفخذ.</p><p dir="RTL">Priorix مخصص للأطفال من سن 9 أشهر فما فوق والمراهقين والبالغين. وسيتم تحديد الوقت المناسب وعدد مرات حقنك بواسطة الطبيب بناءً على التوصيات الرسمية الملائمة.</p><p dir="RTL">ويجب عدم إعطاء اللقاح عن طريق الوريد أبدًا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يتسبب هذا اللقاح، مثل جميع الأدوية الأخرى، في حدوث آثار جانبية، لكن ليس بالضرورة أن يصاب بها<br />جميع الأشخاص.</p><p dir="RTL">كانت الآثار الجانبية التي حدثت خلال التجارب السريرية التي تم فيها استخدام Priorix كما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جدًا</strong> (قد تصيب أكثر من حالة واحدة من كل 10 جرعات لقاح):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار في موضع الحقن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى تصل فيها درجة الحرارة إلى 38 درجة مئوية أو أعلى</p><p dir="RTL"><strong>شائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة من كل 10 جرعات لقاح):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بألم وتورم في موضع الحقن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى تزيد فيها درجة الحرارة عن 39,5 درجة مئوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي (بقع)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الجهاز التنفسي العلوي</p><p dir="RTL"><strong>غير شائعة</strong> (قد تصيب نسبة تصل إلى حالة واحدة من كل 100 جرعة لقاح):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الأذن الوسطى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الغدد اللمفية (الغدد في الرقبة أو الإبط أو الأربية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التوتر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بكاء غير طبيعي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العجز عن النوم (الأرق)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار وتهيج وتدميع العينين (التهاب الملتحمة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الشعب الهوائية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الغدد النكفية (الغدد الموجودة في الوجنة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قيء</p><p>&nbsp;</p><p dir="RTL"><strong>نادرة</strong> (قد تصيب نسبة تصل إلى حالة واحدة من كل 1000 جرعة لقاح):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشنجات تصاحبها حمى عالية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات الحساسية</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد طرح Priorix في الأسواق، تم الإبلاغ عن الآثار الجانبية التالية في حالات قليلة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المفاصل والعضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف نقطي أو في صورة بقع صغيرة أو الإصابة بكدمات بشكل أكثر سهولة مما جرت عليه العادة بسبب انخفاض عدد الصفائح الدموية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعل حساسية مفاجئ مهدد للحياة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى أو التهاب في الدماغ والحبل الشوكي والأعصاب المحيطية يؤدي إلى صعوبة مؤقتة في المشي<br />(عدم الثبات) و/أو فقد مؤقت للتحكم في حركة الجسم، والتهاب بعض الأعصاب، وربما يكون مصحوبًا بالشعور بوخز وتنميل أو فقدان الشعور أو الحركة العادية (متلازمة غيلان باريه)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق الأوعية الدموية أو انسدادها</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمامى عديدة الأشكال (الأعراض وجود بقع حمراء غالبًا ما تثير الحكة وتكون مشابهة للطفح الجلدي الذي تسببه الحصبة وتبدأ في الظهور على الأطراف وفي بعض الأحيان على الوجه وبقية الجسم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض تشبه أعراض الحصبة والنكاف (شاملةً التورم العابر والمؤلم للخصية وتورم الغدد الموجودة<br />في الرقبة)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب استشارة الطبيب أو الصيدلاني أو الممرضة إذا تعرّضت لأيٍّ من الآثار الجانبية. وهذا يتضمن أي آثار جانبية محتملة غير واردة في هذه النشرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- المركز الوطني للتيقظ والسلامة الدوائية </strong><strong>(NPC)</strong></p><ul><li dir="RTL">فاكس: 7662-205-11-966+</li><li dir="RTL">الاتصال بالرقم الموحد: 19999</li><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</li></ul><p dir="RTL"><strong>- </strong><strong>- GlaxoSmithKline</strong><strong> المقر الرئيسي، جدة</strong></p><ul><li dir="RTL">هاتف: 6536666-12-966+</li><li dir="RTL">جوال: 9882-904-56-966+</li><li dir="RTL">البريد الإلكتروني: saudi.safety@gsk.com</li><li dir="RTL">الموقع الإلكتروني: https://gskpro.com/en-sa/<u> </u></li><li dir="RTL">ص. ب. رقم 55850، جدة 21544، المملكة العربية السعودية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإستفسار عن أي معلومات عن هذا المستحضر الدوائي، يرجى الإتصال بالأرقام التالية:</strong></p><p dir="RTL">جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</p><ul><li dir="RTL">هاتف: 6536666-12-966+</li><li dir="RTL">جوال: -56-904-9882966+</li><li dir="RTL">البريد الإلكتروني: gcc.medinfo@gsk.com</li><li dir="RTL">الموقع الإلكتروني: https://gskpro.com/en-sa/</li><li dir="RTL">ص.ب. 55850، جدة 21544، المملكة العربية السعودية.</li></ul><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب حفظ اللقاح بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">لا تستخدم هذا اللقاح بعد تاريخ انتهاء الصلاحية المدون على العبوة الكرتونية بعد كلمة &quot;EXP&quot;.</p><p dir="RTL">يجب حفظه ونقله في ثلاجة (2 - 8 درجات مئوية)</p><p dir="RTL">يجب عدم تجميده</p><p dir="RTL">يُحفظ في العبوة الأصلية للحماية من الضوء</p><p dir="RTL">ينبغي حقن اللقاح بعد تحضيره على الفور. وإذا لم يكن هذا ممكنًا، يجب حفظه على الفور في الثلاجة (في درجة حرارة &nbsp;2 - 8 درجات مئوية) واستخدامه خلال 8 ساعات من تحضيره.</p><p dir="RTL">لا تتخلص من الأدوية برميها في مياه الصرف أو ضمن المخلفات المنزلية. استشر الصيدلي لديك عن كيفية التخلص من الأدوية التي لم تعد تستعملها. فهذه الإجراءات سوف تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات </strong><strong>Priorix</strong><strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الفعَّالة هي: فيروسات الحصبة والنكاف والحصبة الألمانية الحية المُوَهّنة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكوّنات الأخرى هي:</p><p dir="RTL"><u>المسحوق</u>: أحماض أمينية ولاكتوز (لا مائي) ومانيتول وسوربيتول</p><p dir="RTL"><u>المذيب</u>: ماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل لقاح </strong><strong>Priorix</strong><strong> ومحتويات العبوة</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يتم تقديم Priorix في صورة مسحوق ومذيب للمحلول للحقن (المسحوق في قنينة لجرعة واحدة والمذيب في محقنة معبأة مسبقًا (0,5 مل)) مع إبر أو دونها وبأحجام العبوات التالية:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مع إبرة منفصلة: بأحجام عبوة 20 أو 40</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مع إبرتين منفصلتين: بأحجام عبوة 1 أو 10 أو 25 أو 100</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دون إبرة: بأحجام عبوة 1 أو 10 أو 20 أو 25 أو 40 أو 100.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم تقديم Priorix في صورة مسحوق أبيض اللون إلى وردي قليلاً ومذيب صافٍ عديم اللون (ماء للحقن)<br />لتحضير اللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا تتوفر بعض أحجام العبوات في السوق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المصنعة: </strong></p><p dir="RTL">GlaxoSmithKline Biologicals s.a.</p><p dir="RTL">89, rue de l&rsquo;Institut - 1330 Rixensart</p><p dir="RTL">هاتف بلجيكا: 11 81 656 2 (32)&nbsp; فاكس: 00 80 656 2 (32)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شركة التعبئة: </strong></p><p dir="RTL">Glaxo Saudi Arabia Ltd.* جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: ص. ب. رقم 22617 جدة 21416 &ndash; المملكة العربية السعودية</p><p dir="RTL">*إحدى شركات GlaxoSmithKline</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>مالك التسويق المعتمد: </strong></p><p dir="RTL">Glaxo Saudi Arabia Ltd.* جدة، المملكة العربية السعودية</p><p dir="RTL">العنوان: ص. ب. رقم 22617 جدة 21416 &ndash; المملكة العربية السعودية</p><p dir="RTL">*إحدى شركات GlaxoSmithKline</p><p dir="RTL">&nbsp;</p><p dir="RTL">Priorix علامة تجارية مملوكة أو مرخصة لمجموعة شركات GSK</p><p dir="RTL">&nbsp;</p><p dir="RTL">حقوق النشر &copy; لعام 2021 محفوظة لمجموعة شركات GSK أو مانح التراخيص الخاص بها</p><table border="2" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td><p dir="RTL">للإبلاغ عن أي أثر جانبي (آثار جانبية):</p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- المركز الوطني للتيقظ والسلامة الدوائية </strong><strong>(NPC)</strong></p><ul><li dir="RTL">فاكس: 7662-205-11-966+</li><li dir="RTL">الاتصال بالرقم الموحد: 19999</li><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</li></ul><p dir="RTL"><strong>- </strong><strong>- GlaxoSmithKline</strong><strong> المقر الرئيسي، جدة</strong></p><ul><li dir="RTL">هاتف: 6536666-12-966+</li><li dir="RTL">جوال: 9882-904-56-966+</li><li dir="RTL">البريد الإلكتروني: saudi.safety@gsk.com</li><li dir="RTL">الموقع الإلكتروني: https://gskpro.com/en-sa/</li><li dir="RTL">ص. ب. رقم 55850، جدة 21544، المملكة العربية السعودية</li></ul><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><table border="2" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>حول هذا الدواء</strong></p><p dir="RTL">-&nbsp; الدواء هو منتج يؤثر على صحتك واستهلاكه خلافًا للتعليمات يعرضك للخطر.</p><p dir="RTL">-&nbsp; اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلاني الذي صرف الدواء لك.</p><p dir="RTL">-&nbsp; الطبيب والصيدلاني هما الخبيران بالدواء وبنفعه وضرره.</p><p dir="RTL">-&nbsp; لا تقطع مدة العلاج الموصوفة لك من تلقاء نفسك.</p><p dir="RTL">-&nbsp; لا تكرر صرف وصفة الدواء نفسها بدون استشارة الطبيب.</p><p dir="RTL">-&nbsp; احفظ جميع الأدوية بعيدًا عن متناول الأطفال.</p><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">اتحاد الصيادلة العرب</p></td></tr></tbody></table><p dir="RTL"><strong>Priorix</strong><strong>، مسحوق ومذيب للمحلول للحقن في محقنة معبأة مسبقًا</strong></p><p dir="RTL"><strong>لقاح (حي) لعلاج الحصبة والنكاف والحصبة الألمانية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المعلومات التالية خاصة باختصاصيي الرعاية الصحية فحسب:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&rlm;‫كما هو الحال مع جميع اللقاحات القابلة للحقن، يحب توفر الإشراف والعلاج الطبيين المناسبين دومًا في حالة حدوث أي تفاعلات تأقية نادرة عقب التطعيم باللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب الانتظار لحين تبخُّر الكحوليات وغيرها من المواد المطهِّرة من البشرة قبل حقن اللقاح؛ فربما توقِف نشاط الفيروسات الموهنة في اللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب ألا يتم حقن لقاح Priorix داخل الأوعية تحت أي ظرف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لغياب دراسات التوافق، يجب ألا يُخلَط هذا المنتج الدوائي مع منتجات دوائية أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي فحص المذيب واللقاح المُحضّر بالنظر للتأكد من عدم وجود أي جسيمات غريبة و/أو تغيُّر في الأشكال المادية قبل التحضير أو الاستعمال. في حالة ملاحظة أي من هذين الأمرين، لا تستخدم من المذيب أو اللقاح المُحضّر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب تحضير اللقاح عن طريق إضافة كامل محتوى المحقنة المعبأة مسبقًا بالمذيب إلى القنينة التي تحتوي على المسحوق.</p><p dir="RTL">لتوصيل الإبرة بالمحقنة، &nbsp;يُرجى قراءة التعليمات الواردة مع الصورتين 1 و2 بعناية. ومع ذلك، قد تختلف المحقنة المرفقة مع لقاح Priorix قليلاً عن المحقنة المبيَّنة في الرسوم التوضيحية (من دون السن اللولبي).</p><p dir="RTL">في تلك الحالة، ينبغي توصيل الإبرة من دون لفِّها.</p><p dir="RTL"><img alt="" width="537" height="386" src="data:image/png;base64,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" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">احمل دائمًا السرنجة من أنبوب المحقنة، وليس من مكبس المحقنة أو المحبس، وحافظ على الإبرة في محور أنبوب المحقنة (كما هو موضح في الصورة 2). قد يؤدي عدم اتباع هذه التعليمات إلى تشوه المحبس أو تسرب الدواء منه</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا خُلِعَ المحبس أثناء تجميع السرنجة، فيتعين استخدام لقاح جديد (سرنجة وقارورة جديدتان)</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL">1.قم بفك غطاء المحقنة عن طريق لفه عكس اتجاه عقارب الساعة (كما هو موضح في الصورة 1). يُرجى اتباع الخطوات التالية، بغض النظر عما إذا كان المحبس يدور أم لا:</p><p dir="RTL">&nbsp;</p><p dir="RTL">2. قم بتوصيل الإبرة بالسرنجة عن طريق توصيل محور الإبرة بلطف بالمحبس وقم بالتدوير ربع دورة في اتجاه عقارب الساعة حتى تشعر بها تُغلَق بإحكام (كما هو موضح في الصورة 2).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;3. قم بإزالة واقي الإبرة، والذي قد يكون صلبًا</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;4. أضِف المذيب إلى المسحوق. ينبغي رجّ المزيج جيدًا حتى يذوب المسحوق بالكامل في مادة التخفيف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا للتغير الطفيف في درجة حموضة اللقاح، فقد يختلف لون اللقاح المعاد تركيبه من لون الخوخ الصافي إلى الوردي المائل إلى الفوشيا دون أن يؤثر ذلك سلبيًا على درجة فاعلية اللقاح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">5. اسحب كامل محتويات القنينة ثم قم باستخدامه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">6. يتعين استخدام إبرة جديدة لإعطاء اللقاح. قم بفك الإبرة من السرنجة وقم بتوصيل إبرة الحقن بتكرار الخطوة 2 أعلاه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي حقن اللقاح بعد تحضيره على الفور. وإذا لم يكن هذا ممكنًا، يجب حفظه على الفور في الثلاجة (في درجة حرارة 2 - 8 درجات مئوية) واستخدامه خلال 8 ساعات من تحضيره.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب التخلص من أي منتج دوائي غير مستخدم أو نفايات وفقًا للشروط المحلية.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار: UK v14
تاريخ الإصدار: مايو 2020

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Priorix - Powder and solvent for solution for injection in a pre-filled syringe
Measles, Mumps and Rubella vaccine (live)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                After reconstitution, 1 dose (0.5 ml) contains: 

Live attenuated measles virus1 (Schwarz strain)	not less than 103.0 CCID503
Live attenuated mumps virus1 (RIT 4385 strain, derived from Jeryl Lynn strain)	
	not less than 103.7 CCID503
Live attenuated rubella virus2 (Wistar RA 27/3 strain)	not less than 103.0 CCID503 

1 produced in chick embryo cells
2 produced in human diploid (MRC-5) cells
3 Cell Culture Infective Dose 50%

This vaccine contains a trace amount of neomycin.  See section 4.3.

Excipients with known effect
The vaccine contains 9 mg of sorbitol.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for solution for injection in a pre-filled syringe.
The lyophilised Measles-Mumps-Rubella component is a white to slightly pink powder.
The solvent is a clear and colourless solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>PRIORIX is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.</p><p>&nbsp;</p><p>For use in children between 9 to 12 months of age see sections 4.2, 4.4 and 5.1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><strong><em>&nbsp;</em></strong></p><p>The use of PRIORIX should be based on official recommendations.</p><p>&nbsp;</p><p><u>Individuals 12 months of age or older</u></p><p>The dose is 0.5 ml. A second dose should be given according to official recommendations.</p><p>&nbsp;</p><p>PRIORIX may be used in individuals who have previously been vaccinated with another monovalent or combined measles, mumps and rubella vaccine.</p><p>&nbsp;</p><p><u>Infants between 9 and 12 months of age</u></p><p>Infants in their first year of life may not respond sufficiently to the components of the vaccines.&nbsp; In case an epidemiological situation requires vaccinating infants in their first year of life (e.g. outbreak or travel to endemic regions), a second dose of PRIORIX should be given in the second year of life, preferably within three months after the first dose.&nbsp; Under no circumstances should the interval between doses be less than four weeks (see sections 4.4 and 5.1).</p><p>&nbsp;</p><p><u>Infants less than 9 months of age</u></p><p>The safety and efficacy of PRIORIX in infants under 9 months of age has not been established.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p><strong><em>&nbsp;</em></strong></p><p>PRIORIX is for subcutaneous<strong> </strong>injection, although it can also be given by intramuscular injection, in the deltoid region or in the anterolateral area of the thigh (see sections 4.4 and 5.1).</p><p>&nbsp;</p><p>The vaccine should preferably be administered subcutaneously in patients with thrombocytopenia or any coagulation disorder (see section 4.4).</p><p>&nbsp;</p><p>For instructions on reconstitution of the medicinal product before administration see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 or neomycin. A history of contact dermatitis to neomycin is not a contraindication.  For hypersensitivity reactions to egg proteins, see section 4.4.

Severe humoral or cellular (primary or acquired) immunodeficiency,  e.g. severe combined immunodeficiency, agammaglobulinemia and AIDS or symptomatic HIV infection or an age-specific CD4+ T-lymphocyte percentage in children below 12 months: CD4+ <25%; children between 12-35 months: CD4+ < 20%; children between 36-59 months: CD4+ < 15% (see section 4.4).

Pregnancy. Furthermore, pregnancy should be avoided for 1 month following vaccination (see Section 4.6).

As with other vaccines, the administration of PRIORIX should be postponed in subjects suffering from acute severe febrile illness.  The presence of a minor infection, such as a cold, should not result in the deferral of vaccination.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.</p><p>&nbsp;</p><p>Alcohol and other disinfecting agents must be allowed to evaporate from the skin before injection of the vaccine since they can inactivate the attenuated viruses in the vaccine.</p><p>&nbsp;</p><p>Infants in their first year of life may not respond sufficiently to the components of the vaccine, due to the possible interference with maternal antibodies (see sections 4.2 and 5.1).</p><p>&nbsp;</p><p>Due caution should be employed in administration of PRIORIX to individuals with Central Nervous System (CNS) disorder, susceptibility to febrile convulsions or family history of convulsions.&nbsp; Vaccinees with a history of febrile convulsions should be closely followed-up</p><p>&nbsp;</p><p>The measles and mumps components of the vaccine are produced in chick embryo cell culture and may therefore contain traces of egg protein. Persons with a history of anaphylactic, anaphylactoid, or other immediate reactions (e.g. generalised urticaria, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock) subsequent to egg ingestion may be at an enhanced risk of immediate-type hypersensitivity reactions after vaccination, although these types of reactions have been shown to be very rare. Individuals who have experienced anaphylaxis after egg ingestion should be vaccinated with extreme caution, with adequate treatment for anaphylaxis on hand should such a reaction occur.</p><p>&nbsp;</p><p>Limited protection against measles may be obtained by vaccination up to 72 hours after exposure to natural measles.</p><p>&nbsp;</p><p>Syncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a psychogenic response to the needle injection.&nbsp; This can be accompanied by several neurological signs such as transient visual disturbance, paraesthesia and tonic-clonic limb movements during recovery.&nbsp; It is important that procedures are in place to avoid injury from faints.</p><p>&nbsp;</p><p>As with any vaccine, a protective immune response may not be elicited in all vaccinees.</p><p>&nbsp;</p><p>PRIORIX SHOULD UNDER NO CIRCUMSTANCES BE ADMINISTERED INTRAVASCULARLY.</p><p>&nbsp;</p><p><u>Thrombocytopenia</u></p><p>Cases of worsening of thrombocytopenia and cases of recurrence of thrombocytopenia in subjects who suffered thrombocytopenia after the first dose have been reported following vaccination with live measles, mumps and rubella vaccines. MMR-associated thrombocytopenia is rare and generally self-limited. In patients with existing thrombocytopenia or a history of thrombocytopenia after measles, mumps or rubella vaccination the risk-benefit of administering PRIORIX should be carefully evaluated.&nbsp; These patients should be vaccinated with caution and preferably using subcutaneous route.</p><p>&nbsp;</p><p><u>Immunocompromised patients</u></p><p>Vaccination may be considered in patients with selected immune deficiencies where the benefits outweigh the risks (e.g. asymptomatic HIV subjects, IgG subclass deficiencies, congenital neutropenia, chronic granulomatous disease and complement deficiency diseases).</p><p>&nbsp;</p><p>Immunocompromised patients who have no contraindication for this vaccination (see section 4.3) may not respond as well as immunocompetent subjects, therefore some of these patients may acquire measles, mumps or rubella in case of contact, despite appropriate vaccine administration. These patients should be monitored carefully for signs of measles, parotitis and rubella.</p><p>&nbsp;</p><p><u>Transmission</u><br />Transmission of measles and mumps virus from vaccinees to susceptible contacts has never been documented. Pharyngeal excretion of the rubella and measles virus is known to occur about 7 to 28 days after vaccination with peak excretion around the 11th day. However there is no evidence of transmission of these excreted vaccine viruses to susceptible contacts. Transmission of the rubella vaccine virus to infants via breast milk as well as transplacental transmission has been documented without any evidence of clinical disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical studies have demonstrated that PRIORIX can be given simultaneously&nbsp; with any of the following monovalent or combination vaccines [including hexavalent vaccines (DTPa-HBV-IPV/Hib)]: diphtheria-tetanus-acellular pertussis vaccine (DTPa), reduced antigen diphtheria-tetanus-acellular pertussis vaccine (dTpa), <em>Haemophilus influenzae</em> type b vaccine (Hib), inactivated polio vaccine (IPV), hepatitis B vaccine (HBV), hepatitis A vaccine (HAV), meningococcal serogroup B vaccine (MenB), meningococcal serogroup C conjugate vaccine (MenC), meningococcal serogroups A, C, W-135 and Y conjugate vaccine (MenACWY), varicella zoster vaccine (VZV), oral polio vaccine (OPV) and pneumococcal conjugate vaccine in accordance with local recommendations.</p><p>&nbsp;</p><p>Due to an increased risk of fever, tenderness at the injection site, change in eating habits and irritability when Bexsero was co-administered with a combined measles-mumps-rubella-varicella (MMR-V) vaccine, separate vaccination with PRIORIX can be considered when possible.</p><p>&nbsp;</p><p>There are no data to support the use of PRIORIX with any other vaccines.</p><p>&nbsp;</p><p>If PRIORIX is to be given at the same time as another injectable vaccine, the vaccines should always be administered at different injection sites</p><p>&nbsp;</p><p>If not given at the same time, an interval of at least one month is recommended between administration of PRIORIX and other live attenuated vaccines.</p><p>&nbsp;</p><p>If tuberculin testing has to be done it should be carried out before or simultaneously with vaccination since it has been reported that combined measles, mumps and rubella vaccines may cause a temporary depression of tuberculin skin sensitivity. As this anergy may last up to a maximum of 6 weeks, tuberculin testing should not be performed within that period after vaccination to avoid false negative results.</p><p>&nbsp;</p><p>In subjects who have received human gammaglobulins or a blood transfusion, vaccination should be delayed for three months or longer (up to 11 months) depending on the dose of human globulins administered because of the likelihood of vaccine failure due to passively acquired measles, mumps and rubella antibodies.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Fertility</u></p><p>PRIORIX has not been evaluated in fertility studies.</p><p><u>&nbsp;</u></p><p><u>Pregnancy</u></p><p>Pregnant women should not be vaccinated with PRIORIX.</p><p><u>&nbsp;</u></p><p>However, fetal damage has not been documented when measles, mumps or rubella vaccines have been given to pregnant women.</p><p>Even if a theoretical risk cannot be excluded yet, no cases of congenital rubella syndrome have been reported in more than 3500 susceptible women who were unknowingly in early stages of pregnancy when vaccinated with rubella containing vaccines. Therefore, inadvertent vaccination of unknowingly&nbsp;pregnant women with measles, mumps and rubella containing vaccines should not be a reason for termination of pregnancy.</p><p>Pregnancy should be avoided for 1 month following vaccination. Women who intend to become pregnant should be advised to delay.</p><p><u>&nbsp;</u></p><p><u>Breast-feeding</u></p><p>There is limited experience with PRIORIX during breast-feeding.&nbsp; Studies have shown that breast-feeding postpartum women vaccinated with live attenuated rubella vaccines may secrete the virus in breast milk and transmit it to breast-fed infants without evidence of any symptomatic disease.&nbsp; Only in the event the child is confirmed or suspected to be immunodeficient, risks and benefits of vaccinating the mother should be evaluated (see section 4.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">PRIORIX has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Summary of the safety profile</em></strong><br /><br />The safety profile presented below is based on a total of approximately 12,000 subjects administered PRIORIX in clinical trials.</p><p>Adverse reactions which might occur following the use of a combined mumps, measles, rubella vaccine correspond to those observed after administration of the monovalent vaccines alone or in combination.</p><p>&nbsp;</p><p>In controlled clinical studies, signs and symptoms were actively monitored during a 42-day follow-up period. The vaccinees were also requested to report any clinical events during the study period.</p><p>&nbsp;</p><p>The most common adverse reactions following PRIORIX administration were injection site redness and fever &sup3;38&deg;C (rectal) or &sup3;37.5&deg;C (axillary/oral).</p><p>&nbsp;</p><p><strong><em>Tabulated list of adverse reactions</em></strong><br /><br />Adverse reactions reported are listed according to the following frequency:</p><p>Very common: (&sup3; 1/10)</p><p>Common: (&sup3; 1/100 to &lt; 1/10)</p><p>Uncommon: (&sup3; 1/1,000 to &lt; 1/100)</p><p>Rare: (&sup3; 1/10,000 to &lt;1/1,000)</p><p>&nbsp;</p><p><strong><em><u>Clinical trial data</u></em></strong></p><p><strong><em><u>&nbsp;</u></em></strong></p><p><strong><em><u>&nbsp;</u></em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>System Organ Class</strong></p></td><td><p><strong>Frequency</strong></p></td><td><p><strong>Adverse reactions</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>upper respiratory tract infection</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>otitis media</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>lymphadenopathy</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>allergic reactions</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>anorexia</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>nervousness, abnormal crying, insomnia</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>febrile convulsions</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>conjunctivitis</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>bronchitis, cough</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>parotid gland enlargement, diarrhoea, vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>rash</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>redness at the injection site, fever &sup3;38&deg;C (rectal) or &sup3;37.5&deg;C (axillary/oral)</p></td></tr><tr><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>pain and swelling at the injection site, fever &gt;39.5&deg;C (rectal) or &gt;39&deg;C (axillary/oral)</p></td></tr></tbody></table><p>&nbsp;</p><p>In general, the frequency category for adverse reactions was similar for the first and second vaccine doses. The exception to this was pain at the injection site which was &ldquo;Common&rdquo; after the first vaccine dose and &ldquo;Very common&rdquo; after the second vaccine dose.</p><p>&nbsp;</p><p><strong><em><u>Post-marketing data</u></em></strong></p><p>&nbsp;</p><p>The following adverse reactions have been identified in rare occasions during post-marketing surveillance. Because they are reported voluntarily from a population of unknown size, a true estimate of frequency cannot be provided.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>System Organ Class</strong></p></td><td><p><strong>Adverse reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Meningitis, measles-like syndrome, mumps-like syndrome (including orchitis, epididymitis and parotitis)</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Thrombocytopenia, thrombocytopenic purpura</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Anaphylactic reactions</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Encephalitis*, cerebellitis, cerebellitis like symptoms (including transient gait disturbance and transient ataxia),<strong><em> </em></strong>Guillain-Barr&eacute; syndrome, transverse myelitis, peripheral neuritis</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Vasculitis</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Erythema multiforme</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Arthralgia, arthritis</p></td></tr></tbody></table><p><u>&nbsp;</u></p><p><u>&nbsp;</u></p><p>* Encephalitis has been reported with a frequency below 1 per 10 million doses. The risk of encephalitis following administration of the vaccine is far below the risk of encephalitis caused by natural diseases (measles: 1 in 1000 to 2000 cases; mumps: 2-4 in 1000 cases; rubella: approximately 1 in 6000 cases).</p><p>&nbsp;</p><p>Accidental intravascular administration may give rise to severe reactions or even shock.&nbsp; Immediate measures depend on the severity of the reaction (see section 4.4).</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting Hotline: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p><strong>-GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: saudi.safety@gsk.com &nbsp;&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O. Box 55850, Jeddah 21544, Saudi Arabia</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GlaxoSmithKline - Head Office, Jeddah</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/<u> </u></p><ul><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cases of overdose (up to 2 times the recommended dose) have been reported during post-marketing surveillance. No adverse events have been associated to the overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmaco-therapeutic group: Viral vaccine, ATC code: J07BD52</p><p>&nbsp;</p><p><u>Immune response in children 12 months and older</u></p><p>In clinical studies in children aged from 12 months to 2 years PRIORIX has been demonstrated to be highly immunogenic.</p><p>&nbsp;</p><p>Vaccination with a single dose of PRIORIX induced antibodies against measles in 98.1%, against mumps in 94.4% and against rubella in 100% of previously seronegative vaccinees.</p><p>&nbsp;</p><p>Two years after primary vaccination seroconversion rates were 93.4% for measles, 94.4% for mumps and 100% for rubella.</p><p>&nbsp;</p><p>Although there are no data available concerning the protective efficacy of PRIORIX, immunogenicity is accepted as an indication of protective efficacy. However, some field studies report that the effectiveness against mumps may be lower than the observed seroconversion rates to mumps.</p><p>&nbsp;</p><p><u>Immune response in children aged 9 to 10 months</u></p><p>A clinical trial enrolled 300 healthy children 9 to 10 months of age at the time of first vaccine dose. Of these 147 subjects received PRIORIX and VARILRIX concomitantly. Seroconversion rates for measles, mumps and rubella were 92.6%, 91.5% and 100%, respectively. The seroconversion rates reported following the second dose given 3 months after the first dose were 100% for measles, 99.2% for mumps and 100% for rubella. Therefore a second dose of PRIORIX should be given within three months to provide optimal immune responses.</p><p>&nbsp;</p><p><u>Adolescents and adults</u></p><p>The safety and immunogenicity of PRIORIX in adolescents and adults has not been specifically studied in clinical trials.</p><p>&nbsp;</p><p><u>Intramuscular route of administration</u></p><p>A limited number of subjects received PRIORIX intramuscularly in clinical trials. The seroconversion rates to the three components were comparable to those seen after subcutaneous administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An evaluation of pharmacokinetics in vaccines is not necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:.5in; margin-right:34.3pt; text-align:justify">Non-clinical data reveal no special hazard for humans based on general safety studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Powder: </em></p><p>Amino acids</p><p>Lactose (anhydrous)</p><p>Mannitol</p><p>Sorbitol</p><p><em>&nbsp;</em></p><p><em>Solvent</em>:</p><p>Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.

The vaccine should be injected promptly after reconstitution.  If this is not possible, it must be stored at 2°C-8°C and used within 8 hours of reconstitution.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store and transport refrigerated (2&deg;C-8&deg;C).</p><p>Do not freeze.</p><p>Store in the original package in order to protect from light.</p><p>&nbsp;</p><p>For storage conditions after reconstitution of the medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Powder in vial (Type I glass) with rubber stopper.</p><p>0.5 ml of solution in pre-filled syringe (Type I glass) with rubber plunger stopper with or without needles in the following pack sizes:</p><p>&nbsp;&nbsp;&nbsp; - with 1 separate needle: pack sizes of 20 or 40</p><p>&nbsp;&nbsp;&nbsp; - with 2 separate needles: pack sizes of 1, 10, 25 or 100</p><p>&nbsp;&nbsp;&nbsp; - without needle: pack sizes of 1, 10, 20, 25, 40 or 100.</p><p>&nbsp;</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The solvent and the reconstituted vaccine should be inspected visually for any foreign particulate matter and/or variation of physical aspects prior to reconstitution or administration. In the event of either being observed, do not use the solvent or the reconstituted vaccine.</p><p>&nbsp;</p><p>The vaccine must be reconstituted by adding the entire contents of the pre-filled syringe of solvent to the vial containing the powder.</p><p>&nbsp;</p><p>To attach the needle to the syringe, carefully read the instructions given with pictures 1 and 2. However, the syringe provided with PRIORIX might be slightly different (without screw thread) than the syringe illustrated.&nbsp; In that case, the needle should be attached without screwing.</p><p>&nbsp;</p><p><img alt="" width="575" height="342" src="data:image/png;base64,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" /></p><p>Always hold the syringe by the barrel, not by the syringe plunger or the Luer Lock Adaptor (LLA), and maintain the needle in the axis of the syringe (as illustrated in picture 2). Failure to do this may cause the LLA to become distorted and leak.</p><p>&nbsp;</p><p>During assembly of the syringe, if the LLA comes off, a new vaccine dose (new syringe and vial) should be used.</p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp; Unscrew the syringe cap by twisting it anticlockwise (as illustrated in picture 1).&nbsp;</p><p>Whether the LLA is rotating or not, please follow below steps:</p><p>&nbsp;</p><p>2.&nbsp;&nbsp;&nbsp; Attach the needle to the syringe by gently connecting the needle hub into the LLA and rotate a quarter turn clockwise until you feel it lock (as illustrated in picture 2).</p><p>&nbsp;</p><p>3.&nbsp;&nbsp;&nbsp; Remove the needle protector, which may be stiff.</p><p>&nbsp;</p><p>4.&nbsp;&nbsp;&nbsp; Add the solvent to the powder. The mixture should be well shaken until the powder is completely dissolved in the solvent.</p><p>&nbsp;</p><p>Due to minor variation of its pH, the reconstituted vaccine may vary in colour from clear peach to fuchsia pink without deterioration of the vaccine potency.</p><p>&nbsp;</p><p>5.&nbsp;&nbsp; Withdraw the entire contents of the vial and administer it.</p><p>6.&nbsp;&nbsp;&nbsp; A new needle should be used to administer the vaccine. Unscrew the needle from the syringe and attach the injection needle by repeating step 2 above.</p><p>&nbsp;</p><p>Contacts with disinfectants should be avoided (see section 4.4).</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                GlaxoSmithKline Biologicals s.a. 
89, rue de l’Institut - 1330 Rixensart 
Belgium Tel: (32) 2 656 81 11 Fax: (32) 2 656 80 00 

 packed by: 

Glaxo Saudi Arabia Ltd.* Jeddah, KSA 
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia 
*member of the GlaxoSmithKline group of companies

. Marketing Authorization holder: 

Glaxo Saudi Arabia Ltd.* Jeddah, KSA 
Address: P.O. Box 22617 Jeddah 21416 – Kingdom of Saudi Arabia 
*member of the GlaxoSmithKline group of companies

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06 May 2020

Priorix is a trademark owned by or licensed to the GSK group of companies
© 2021 GlaxoSmithKline group of companies. All rights reserved.

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>